# A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer

> clinical trial · VERIFIED · 2026-06-18

Status: RECRUITING · Sponsor: AbbVie · Condition: Metastatic Colorectal Cancer

- Company: AbbVie
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT06820463

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.